In an episode of Making It In Manufacturing, John Gagliardi of Samsung Biologics shares how leading CDMOs evolve beyond scale into true strategic partners through long-term value creation, integrated ADC capabilities, and a sharp focus on lifecycle management. Gagliardi also explores the strategic importance of the Lilly Gateway Labs collaboration and what high-quality, co-located biomanufacturing partnerships look like in practice.
For a practical look at where biomanufacturing partnerships are heading, watch the full episode here.
In an episode of Making It In Manufacturing, John Gagliardi of Samsung Biologics shares how leading CDMOs evolve beyond scale into true strategic partners through long-term value creation, integrated ADC capabilities, and a sharp focus on lifecycle management. Gagliardi also explores the strategic importance of the Lilly Gateway Labs collaboration and what high-quality, co-located biomanufacturing partnerships look like in practice.
For a practical look at where biomanufacturing partnerships are heading, watch the full episode here.
Share article
Related Content